Goodman Group has patented a hemostatic device for closing puncture holes in blood vessels. The device includes a tubular member, positioning member, hemostatic agent, push-out member, and operation units. A switching mechanism ensures sequential operations for effective closure. GlobalData’s report on Goodman Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.

According to GlobalData’s company profile on Goodman Group, Customized implants was a key innovation area identified from patents. Goodman Group's grant share as of January 2024 was 14%. Grant share is based on the ratio of number of grants to total number of patents.

Hemostatic device for closing puncture holes in blood vessels

Source: United States Patent and Trademark Office (USPTO). Credit: Goodman Group

A recently granted patent (Publication Number: US11849953B2) discloses a hemostatic device designed to close a puncture hole extending from a blood vessel opening to the skin. The device comprises a first tubular member, a positioning member with an extending section and an engagement section, a hemostatic agent, and a push-out member to dispense the agent. The device also includes a housing, a first operation unit for controlling movement, a switching mechanism to regulate operations sequentially, a coupling section for connecting to another tubular member, and a second operation unit for coupling operations. The device's design ensures step-by-step control of operations to effectively close the puncture hole.

Furthermore, the patent details the switching mechanism's components, the operation units' functions, and the movement directions for each operation. The device's design allows for precise control over the closure process, ensuring that each step is completed before moving on to the next. Additionally, the device includes a balloon engagement section that can switch between inflated and contracted states to effectively engage with the opening for closure. Overall, the hemostatic device described in the patent offers a comprehensive solution for closing puncture holes in blood vessels, providing a controlled and efficient process for healthcare professionals.

To know more about GlobalData’s detailed insights on Goodman Group, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.